Abstract
Background: Several studies demonstrated that P wave dispersion (PWD) increased after coronary occlusion. The effect of primary percutaneous coronary intervention (PCI) on PWD needs to be elucidated.
Methods: The study consisted of 125 patients with acute myocardial infarction (110 men, mean age 59.8 ± 7.8 years) undergoing primary PCI. The patients were divided into three groups according to thrombolysis in myocardial infarction myocardial perfusion grade (TMPG) after successful PCI. Groups 1 (n = 12), 2 (n = 9), and 3 (n = 104) included the patients with TMPG 0/1, 2, 3, respectively. Electrocardiograms were obtained before and approximately 66 ± 18 minutes after PCI.
Results: PWD and Pmaximum after PCI were significantly lower than the preintervention values (P < 0.001 for both). When PWD and Pmaximum values after PCI were compared among groups, PWD and Pmaximum in groups 1 and 2 were found to be higher than those of group 3 (P < 0.001 for PWD and Pmaximum). Atrial fibrillation (AF) occurred in 14 patients. Pmaximum and PWD in patients with AF were higher compared to those of the patients without AF (P < 0.001 for both P wave parameters). Also more frequent AF attacks were observed in group 1 compared to group 3 (P < 0.001).
Conclusions: PWD and Pmaximum after primary PCI were lower compared to the preintervention values. Prolonged PWD in patients with poor myocardial perfusion can contribute to increased mortality, and also it can can be combined with ST segment resolution to predict clinical reperfusion and might help in predicting AF.
Keywords: P wave dispersion, primary percutaneous coronary intervention
P wave dispersion (PWD) constitutes an important contribution to the field of noninvasive electrocardiology and is defined as the difference between the longest and shortest P wave duration (Pdur) recorded from surface electrocardiogram (ECG) leads. PWD has been thorougly examined in a number of diseases including hypertension, angina pectoris, coronary artery bypass surgery, and paroxysmal atrial fibrillation (AF). 1 , 2 , 3 , 4
Acute myocardial infarction (AMI) is the leading cause of death in North America and Europe. 5 The primary goal in the management of AMI is to institute reperfusion therapy as quickly as possible. Catheter‐based strategies for reperfusion of the occluded infarct‐related artery (IRA) in patients with AMI is a rapidly evolving field. 6 Several studies revealed that primary percutaneous coronary intervention (PCI) has more favorable effects than those of classical therapy including thrombolytic therapy.
Although acute effects of elective PCI on atrial conduction abnormalities manifested by increased PWD and P maximum values were shown in a well‐designated clinical study, 7 the effects of primary PCI on PWD in patients with ST segment elevation myocardial infarction (STEMI) and the clinical significance of Pdur changes have remained to be elucidated.
In this clinical study, we aimed to investigate the effects of primary PCI on atrial conduction properties defined simply as PWD and its clinical sequela in patients with STEMI.
METHODS
Patients
The study population consisted of 125 patients presenting with STEMI (110 men, mean age 59.8 ± 7.8 years) undergoing successful primary PCI. The study group was divided into three groups according to thrombolysis in myocardial infarction (TIMI) myocardial perfusion grade (TMPG) immediately after primary PCI. Group 1 comprised patients with TMPG 0/1; group 2, TMPG 2; and group 3, TMPG 3. Exclusion criteria were shown in Table 1. Written informed consents were obtained from all the patients eligible for the study.
Table 1.
1. Severe valvular heart disease of hemodynamic significance (Mitral valve disease, aortic insufficiency, etc.) |
2. Severe pulmonary hypertension |
3. History of asthma or chronic obstructive lung disease |
4. Atrial fibrillation, flutter, or any other atrial tachyarrhythmias requiring antiarrhythmic theraphy |
5. History of taking antiarrhythmic drugs within 1 month including digoxin |
6. Hypertrophic, restrictive and dilated cardiomyopathy with any etiology |
7. Lower than TIMI flow grade 3 after primary PCI |
8. Severe renal or hepatic failure |
9. Hyperthyroidism |
10. History of coronary artery bypass surgery |
The diagnosis of AMI was established using American College of Cardiology/European Society of Cardiology criteria. 8
Adjuntive Therapy
On admission, all the patients received aspirin 300 mg a day, heparin, clopidogrel with a starting dose of 300 mg and a maintenance dose of 75 mg, and nitroglycerine. Primary PCI was performed as quickly as possible (average door to first balloon time 52 ± 18 minutes).The use of other medications, including GpIIb/IIIa receptor antogonists, was at the discretion of the attending operator.
Coronary Intervention and Analysis of TMPG
Primary angioplasty and stenting procedure was performed according to standard techniques. The technical aspects of the procedure, including choice of stents, duration, and pressure of inflation, were determined by individual operators. To achieve maximal dilatation, each coronary angiogram was preceded by intracoronary injection of 125 μg nitroglycerin. All angiographic analyses (Siemens HICOR T.O.P Image System, Forchheim, Germany) were performed off‐line by two cardiologists blinded to all data of the patients at our catheter laboratory.
Successful coronary intervention was defined as TIMI grade 3 flow and residual stenosis of less than 30% after the angioplasty procedure. Unsuccessful angiographic percutaneous transluminal coronary angioplasty (PTCA) was defined when TIMI flow was scored 0 or 1 at any level of residual stenosis.
TMPG was graded densitometrically based on visual assessment of relative contrast opacification of the myocardial territory subtended by the infarct vessel in relation to the epicardial density as described by van't Hof et al. 9 Blush score 0 was defined as the absence of contrast opacification in the myocardial infarct zone or persistent stain without washout; blush 1, minimal contrast opacification; blush 2, reduced but clearly evident blush in the infarct zone compared to the ipsilateral or contralateral noninvolved epicardial vessel(s); blush 3, myocardial contrast filling equal to or greater than that seen in the noninvolved epicardial vessel(s). To allow blush grading, the length of the angiographic run was kept long enough to see the venous phase of the contrast medium passage. These angiographic runs were made using identical views according to the IRA and thus assuring comparable evaluations in all patients. When the left coronary artery was involved, the final angiogram was obtained in the left lateral view. If the IRA was the right coronary artery, the final angiogram was obtained in the right oblique view. Blush scores were analyzed by two different interventional cardiologists blinded to patients' clinical data. Intra‐ and interobserver variability were obtained from random sample of 50 patients. Intra‐ and interobserver variability for blush score 0/1 were 8.5% and 11.5%, respectively. While intra‐ and interobserver variability for blush score 2 were 1.5% and 2.5%, respectively, and both intraobserver and interobserver variability for blush score 3 was 0%.
Transthoracic echocardiography was performed using ESAOTE 2.5 MHz probe (ESAOTE, Genova, Italy) at the left lateral decubitis position before primary PCI.
Surface ECG
Twelve‐lead surface ECG was recorded from all patients before and at an average of 66 ± 18 minutes after primary PCI procedure (Hewlett Packard M1700A, Houston, TX, USA). The ECG recordings were obtained at a paper speed of 50 mm/s and signal size of 10 mm/mV at sinus rhtym.
P Wave Duration Analyses
The P wave duration (Pdur) measurements were calculated from 12‐lead surface ECGs recorded simultaneously. Manual measurements of Pdur were performed with digital ECG recordings on a high‐resolution screen by two cardiologists not aware of the patients' clinical data and outcomes. The P‐wave onset was defined as the first atrial deflection from the isoelectric line and the offset was the return of the atrial signal to baseline. Mean Pdur was calculated as the mean value of P duration in each lead. The difference between the maximum and minimum P wave duration was defined as PWD: (PWD (ms) = Pmaximum− Pminimum). Two investigators blinded to patients' clinical and outcome data calculated P‐wave durations. Intra‐ and interobserver variability were obtained from random ECG recordings of 50 patients. While intra‐ and interobserver variability for Pmaximum were 3.5% and 4%, respectively; intra‐ and interobserver variability for PWD were 2.5% and 3.3%, respectively.
Statistics
Results are expressed as the mean ± SD and percents. The Levene's test was used to analyze the distribution characteristics of variables. The differences between groups were tested for significance by chi‐square, one‐way analysis of variance and Kruskal–Wallis test. Two‐tailed paired t‐test was used to compare the mean values of ECG measurements of Pdur before and after primary PCI. Independent samples t‐test and Mann–Whitney U test were used to compare P wave duration values between patients with AF and without AF after primary PCI. The relationship between variables was analyzed with Kendall's tau‐b and Spearman correlation test. Differences and correlations were considered at P < 0.05. Statistical analyses were performed by using SPSS 10.0 Statistical Package Program for Windows (SPSS Inc., Chicago, IL, USA).
RESULTS
The study included 125 consecutive patients (110 men, mean age 59.8 ± 7.8 years). Group 1 consisted of 12; group 2, 9; and group 3, 104 patients. When clinical, angiographic, and echocardiographic variables were compared with each other among groups, no statistically significant difference was found (Table 2).
Table 2.
Group 1 (n = 12) | Group 2 (n = 9) | Group 3 (n = 104) | P Value | |
---|---|---|---|---|
Mean age (years) | 61.9 ± 7.3 | 56.4 ± 8.3 | 59.9 ± 7.8 | 0.25a |
Sex (M), n (%) | 10 (83) | 8 (80) | 92 (89) | 0.59b |
Hypercholesterolemia, n (%) | 4 (33) | 1 (11) | 37 (35) | 0.25b |
Diabetes mellitus, n (%) | 5 (41) | 3 (30) | 22 (21) | 0.26b |
Hypertension, n (%) | 8 (66) | 2 (22) | 63 (60) | 0.15b |
FHPCAD, n (%) | 4 (33) | 3 (33) | 19 (18) | 0.36b |
Smoking, n (%) | 8 (66) | 4 (44) | 49 (47) | 0.38b |
Time from symptoms onset to first balloon inflation (minutes) | 216 ± 94 | 234 ± 78 | 198 ± 98 | 0.54a |
LVEF (%) | 51.5 ± 3.6 | 54.0 ± 4.0 | 54.1 ± 4.5 | 0.18a |
LA (mm) | 41.9 ± 1.9 | 41.6 ± 1.1 | 42.0 ± 1.3 | 0.67a |
HR (bpm) | 73.6 ± 7.9 | 72.5 ± 8.1 | 72.9 ± 9.7 | 0.95a |
IRA, n (%) | ||||
LAD | 7 (58.3) | 3 (30) | 24 (23) | 0.13b |
CX | 1 (8.3) | 1 (10) | 18 (17.3) | |
RCA | 4 (33.3) | 6 (60) | 61 (58.6) |
M = male; FHPCAD, family history of premature coronary artery disease; LVEF = left ventricular ejection fraction; LA = left atrium; HR = heart rate; LAD = left anterior descending coronary artery; CX = circumflex coronary artery; RCA = right coronary artery.
Values are mean ± SD or n (%).
aOne‐way ANOVA test.
bChi‐square test.
When preintervention Pdur, PWD, and heart rates were compared to postintervention values, Pmaximum and PWD values after primary PCI were found significantly lower than the values of preintervention as shown in Table 3 (P < 0.001 for both of them).
Table 3.
Before PCI (n = 125) | After PCI (n = 125) | P Value a | |
---|---|---|---|
P maximum (ms) | 117.08 ± 11.00 | 100.44 ± 15.22 | <0.001 |
P minimum (ms) | 45.56 ± 10.21 | 48.00 ± 10.10 | 0.06 |
P dispersion (ms) | 69.52 ± 14.61 | 52.44 ± 18.75 | <0.001 |
Heart rate (bpm) | 72.90 ± 9.41 | 71.62 ± 11.21 | 0.18 |
Values are presented as mean ± SD.
aPaired t‐test.
When PWD and Pdur after primary PCI were compared to those of other groups each, statistically significant difference was seen among groups. PWD and Pmaximum in groups 1 and 2 were higher than those of group 3 as shown in Table 4 (P < 0.001 for PWD and Pmaximum).
Table 4.
Group 1 (n = 12) | Group 2 (n = 9) | Group 3 (n = 104) | P Value | |
---|---|---|---|---|
PWD (ms) | ||||
Before | 70.0 ± 6.7 | 75.0 ± 9.4 | 68.9 ± 15.6 | 0.46a |
After | 89.1 ± 6.6λ | 76.0 ± 13.7λλ | 45.8 ± 12.2λλλ | <0.001b |
P maximum (ms) | ||||
Before | 114.1 ± 9.9 | 119.0 ± 5.16 | 117.2 ± 11.5 | 0.61a |
After | 133.3 ± 7.7γ | 123.2 ± 4.6γγ | 94.4 ± 6.5γγγ | <0.001b |
P minimum (ms) | ||||
Before | 44.1 ± 5.1 | 44.0 ± 8.4 | 48.3 ± 10.6 | 0.32a |
After | 44.2 ± 5.2 | 46.9 ± 8.2 | 48.5 ± 10.7 | 0.53a |
PWD, P wave dispersion.
Values are presented as mean ± SD.
aKruskal–Wallis test.
bBonferroni adjusted Mann–Whitney U test.
P = 0.02 for λ versus λλ, P < 0.001 for λ versus λλλ and λλ versus λλλ.
P = 0.005 for γ versus γγ, P < 0.001 for γ versus γγγ and γγ versus γγγ.
When the patients were subdivided into groups according to IRA, P wave measurements before and after primary PCI were not different among groups.
Fourteen patients suffered from AF in‐hospital follow‐up period (mean in‐hospital stay 7 ± 2 days). AF was electrically converted to sinus rhythm in 2 patients and pharmacologically converted to sinus rhythm in 6 patients. AF spontaneously converted to sinus rhythm in 6 patients. Eight patients suffered from AF in group 1, 2 patients in group 2, and 1 patient in group 3. Values of Pmaximum and PWD in patients with AF in‐hospital follow‐up period were higher compared to those of the patients without AF as shown in Table 5 (P < 0.001 for both Pmaximum and PWD).
Table 5.
AF (n = 14) | No AF (n = 111) | P VALUE | |
---|---|---|---|
PWD (ms) | |||
Before | 71.4 ± 8.1 | 69.2 ± 15.2 | 0.79a |
After | 80.7 ± 17.8 | 48.8 ± 15.6 | <0.001b |
P maximum (ms) | |||
Before | 117.8 ± 8.1 | 116.9 ± 11.3 | 0.86a |
After | 129.2 ± 16.3 | 96.2 ± 10.5 | <0.001b |
P minimum (ms) | |||
Before | 46.2 ± 7.4 | 47.7 ± 10.5 | 0.91a |
After | 48.5 ± 6.3 | 47.9 ± 10.4 | 0.31b |
AF, Atrial fibrillation; PWD, P wave dispersion.
Values are mean ± SD.
aMann–Whitney U test.
bIndependent samples t‐test.
When in‐hospital AF frequencies were analyzed, significantly higher frequency of AF was found in group 1 compared to group 3 (P < 0.001 for group 1 vs 3).
Strong negative correlation was found between AF and TMPG 1(r =−0.975, P < 0.001). Additionally, moderate negative correlation was seen between AF and PWD after primary PCI (r =−0.55, P < 0.001).
DISCUSSION
It has been shown that P wave duration changes can occur in acute coronary syndromes, induced myocardial ischemia, 10 , 11 , 12 and after elective coronary angioplasty. 5 Rapid restoration of patency by catheter‐based percutaneous intervention can result in excellent outcomes in patients presenting with STEMI. 13 However, the changes in P wave duration have not been thoroughly studied in patients with STEMI undergoing primary PCI. We found that the values of Pmaximum and PWD decreased significantly after primary PCI compared to the preintervention values. Most importantly, the patients having poor myocardial perfusion, which correlates with high mortality rates even after adjusting for the presence of TIMI grade 3 flow or a normal TIMI frame count, had significantly higher values of Pmaximum and PWD compared to those of the patients with good myocardial perfusion grades after primary PCI. Moreover, the values of Pmaximum and PWD in patients with in‐hospital follow‐up period were higher compared to those of the patients without AF.
In spite of the fact that the flow in epicardial IRA in patients with STEMI can be accomplished by catheter‐based interventions in most of the patients; unfortunately, adequate myocardial perfusion may not be achieved in all the patients with TIMI grade 3 flow. 14 , 15 TMPG is a multivariate predictor of a 30‐day mortality independent of age, gender, admission pulse, anterior myocardial infarction location, corrected TIMI frame count, or TIMI flow grade. 16 Patients with TIMI 3 flow in the IRA after PCI and poor myocardial perfusion (TMPG 0 or 1) have a mortality of 5.4%, which is significantly higher than that in patients with TIMI 3 flow and TMPG 2 (4.4%) or TMPG 3 (2%, P < 0.01). 16 We considered that in our study poor myocardial perfusion grade after primary PCI can cause PWD and Pmaximum prolongation. Probably, the increased PWD and Pmaximum in patients with poor myocardial perfusion after primary PCI is a result of the ongoing tissue ischemia inducing in homogeneous and discontinuous atrial conduction. We speculated that high PWD values in patients with poor myocardial perfusion after primary PCI might have a role in high mortality rates encountered in this group of patients.
ST segment resolution on the surface 12‐lead ECG is a strong predictor of outcome in AMI patients; its absence is a better predictor of an occluded rather than patent IRA. 14 , 17 , 18 Resolution of ST segment elevation by more than 70% is correlated with effective tissue level reperfusion. We consider that PWD when it is combined with ST segment resolution can provide additive data about tissue perfusion in patients STEMI undergoing primary PCI. We hope that future large‐scale studies will shed light on the role of PWD on myocardial tissue level reperfusion.
Atrial fibrillation occurs in 10–20% of patients with AMI. 19 AF in AMI is associated with increased mortality and stroke particularly in patients with acute anterior wall infarction. 20 PWD has been proven to be a sensitive and specific ECG predictor of AF in the various clinical settings such as hypertension, coronary artery disease, and coronary artery bypass surgery. Concordantly, we observed that the patients with AF had higher PWD and Pmaximum values compared to those of the patients without AF. Therefore, PWD might help in the prediction of AF in patients with AMI undergoing primary PCI. In our study, the patients with poor myocardial perfusion showed more frequent AF compared to the patients with good myocardial perfusion. It has been shown that AF increases mortality and morbidity in AMI patients. We speculated that high PWD values in patients with poor myocardial perfusion after primary PCI might have a role in high mortality rates encountered in this group of patients by increasing of frequency of in‐hospital AF.
CONCLUSION
PWD and Pmaximum values after primary PCI were lower compared to the preintervention values. Postprocedure prolonged PWD in patients with poor myocardial perfusion can contribute to increased mortality, can be combined with ST segment resolution to predict clinical reperfusion and might help in predicting of AF in patients with STEMI undergoing primary PCI.
REFERENCES
- 1. Dilaveris PE, Andrikopoulos GK, Metaxas G, et al Effects of ischemia on P wave dispersion and maximum P wave duration during spontaneous anginal episodes. Pacing Clin Electrophysiol 1999;22: 1640–1647. [DOI] [PubMed] [Google Scholar]
- 2. Aytemir K, Ozer N, Atalar E, et al P wave dispersion on 12‐lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000;23: 1109–1112. [DOI] [PubMed] [Google Scholar]
- 3. Ozer N, Aytemir K, Atalar E, et al P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000;23: 1859–1862. [DOI] [PubMed] [Google Scholar]
- 4. Dilaveris PE, Gialafos JE. P‐wave dispersion: A novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 2001;6: 159–165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. 2002 Heart and Stroke Statistical Update. Dallas , TX , American Heart Association , 2002.
- 6. Grines CL, Marsalese DL, Brodie B, et al Safety and cost‐effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI‐II investigators. Primary angioplasty in myocardial infarction. J Am Coll Cardiol 1998;31: 967–972. [DOI] [PubMed] [Google Scholar]
- 7. Ozmen F, Atalar E, Aytemir K, et al Effect of balloon‐induced acute ischaemia on P wave dispersion during percutaneous transluminal coronary angioplasty. Europace 2001;3: 299–303. [DOI] [PubMed] [Google Scholar]
- 8. Alpert JS, Thygesen K, Antman E, et al Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36: 959–969. [DOI] [PubMed] [Google Scholar]
- 9. Van 't Hof AW, Liem A, Suryapranata H, et al Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998;97: 2302–2306. [DOI] [PubMed] [Google Scholar]
- 10. Pande AK, Meier B, Urban P, et al Intracoronary electrocardiogram during coronary angioplasty. Am Heart J 1992;124: 337–341. [DOI] [PubMed] [Google Scholar]
- 11. Myrianthefs MM, Shandling AH, Startt‐Selvester RH, et al Analysis of the signal‐averaged P‐wave duration in patients with percutaneous coronary angioplasty‐induced myocardial ischemia. Am J Cardiol 1992;70: 728–732. [DOI] [PubMed] [Google Scholar]
- 12. Myrianthefs MM, Ellestad MH, Startt‐Selvester RH, et al Significance of signal‐averaged P‐wave changes during exercise in patients with coronary artery disease and correlation with angiographic findings. Am J Cardiol 1991;68: 1619–1624. [DOI] [PubMed] [Google Scholar]
- 13. Timmis G, Timmis S. The restoration of coronary blood flow in acute myocardial infarction. J Interv Cardiol 1998;11: S9–S17. [Google Scholar]
- 14. Davies CH, Ormerod OJ. Failed coronary thrombolysis. Lancet 1998;351: 1191–1196. [DOI] [PubMed] [Google Scholar]
- 15. Ito H, Okamura A, Iwakura K, et al Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996;93: 1993–1999. [DOI] [PubMed] [Google Scholar]
- 16. Gibson CM, Cannon CP, Murphy SA, et al Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000;101: 125–130. [DOI] [PubMed] [Google Scholar]
- 17. Schroder R, Wegscheider K, Schroder K, et al Extent of early ST segment elevation resolution: A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol 1995;26: 1657–1664. [DOI] [PubMed] [Google Scholar]
- 18. Department of Cardiology, Ziekenhuis de Weezenlanden, Zwolle, Netherlands . Clinical value of 12‐lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet 1997;350: 615–619. [DOI] [PubMed] [Google Scholar]
- 19. Pedersen OD, Bagger H, Kober L, et al The occurrence and prognostic significance of atrial fibrillation/flutter following acute myocardial infarction. TRACE Study group. Trandolapril Cardiac Evalution. Eur Heart J 1999;20: 748–754. [DOI] [PubMed] [Google Scholar]
- 20. Mahaffey KW, Granger CB, Sloan MA, et al Risk factors for in‐hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: Results from GUSTO‐I. Circulation 1998;97: 757–764. [DOI] [PubMed] [Google Scholar]